39 PRIMECAP Management Charles River Laboratories International Trades
PRIMECAP Management acquired 274 Thousand Charles River Laboratories International shares worth $60.7 Million. That's 0.05% of their equity portfolio (171st largest holding). PRIMECAP Management started to build up the position in Charles River Laboratories International in Q1 2013 and continued to invest until Q3 2013. Since then they sold 1.42 Million shares. The stake costed the investor $11.6 Million, netting the investor a gain of 422% so far.
News about Charles River Laboratories International Inc. and PRIMECAP Management
T. Rowe Price Expands Use of Cloud-Based Charles River® IMS
BOSTON–(BUSINESS WIRE)–#assetmanagement–Charles River Development, a State Street Company, announced today that T. Rowe Price will transition to Charles Rive...
Charles River Laboratories to Present at Barclays Global Healthcare Conference
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Barclays 26th Annual Global Healthcare Conference on W...
Charles River Laboratories to Present at Evercore ISI Investor Conference
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 6th Annual Evercore ISI HealthCONx Conference on Wedne...
Charles River Laboratories to Host Virtual Investor Day
Charles River Laboratories International, Inc. (NYSE: CRL) announced that it will host a virtual Meeting with Management on Thursday, September 21st, beginni...